Edwards Lifesciences Corporation (BMV:EW)

Edwards Lifesciences Ratios and Metrics

Market cap in millions MXN. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Oct 9, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Cap	805,068	810,255	852,276	843,934	1,503,438	1,059,070
Market Cap Growth	4.20%	-4.93%	0.99%	-43.87%	41.96%	16.76%
Enterprise Value	743,802	750,104	835,519	833,717	1,488,525	1,045,405
PE Ratio	10.29	10.62	33.15	30.58	54.43	70.18
Forward PE	28.71	31.19	28.41	30.35	52.98	43.34
PEG Ratio	-	3.69	2.77	2.95	3.38	3.13
PS Ratio	7.51	8.01	9.15	10.17	15.45	12.98
PB Ratio	4.02	4.36	6.89	7.82	13.85	12.45
P/TBV Ratio	76.91	4.44	6.99	8.02	14.01	12.60
P/FCF Ratio	-	150.31	71.30	46.62	57.49	87.99
P/OCF Ratio	-	80.35	51.17	37.26	46.68	54.02
EV/Sales Ratio	7.05	7.42	8.97	10.04	15.30	12.82
EV/EBITDA Ratio	22.67	26.31	30.91	27.37	43.86	55.95
EV/EBIT Ratio	25.24	29.27	34.33	29.92	47.36	62.63
EV/FCF Ratio	67.09	139.15	69.90	46.05	56.92	86.85
Debt / Equity Ratio	0.06	0.07	0.10	0.11	0.11	0.15
Debt / EBITDA Ratio	0.46	0.46	0.47	0.42	0.38	0.69
Debt / FCF Ratio	1.20	2.42	1.07	0.71	0.49	1.07
Asset Turnover	0.43	0.49	0.57	0.53	0.66	0.64
Inventory Turnover	1.08	1.12	1.10	0.90	1.63	1.50
Quick Ratio	3.53	3.12	2.06	1.87	2.07	2.24
Current Ratio	4.68	4.18	3.38	3.03	3.08	3.46
Return on Equity (ROE)	11.90%	16.63%	19.48%	22.74%	28.88%	18.88%
Return on Assets (ROA)	8.87%	11.09%	13.18%	15.55%	18.97%	11.75%
Return on Capital (ROIC)	15.04%	17.40%	18.23%	21.56%	27.15%	17.79%
Return on Capital Employed (ROCE)	11.74%	13.98%	16.96%	20.33%	24.47%	15.05%
Earnings Yield	9.72%	9.42%	3.02%	3.27%	1.84%	1.42%
FCF Yield	1.38%	0.67%	1.40%	2.15%	1.74%	1.14%
Buyback Yield / Dilution	2.38%	2.25%	1.55%	3.48%	0.44%	0.85%
Total Shareholder Return	-	2.25%	1.55%	3.48%	0.44%	0.85%

Updated Jun 30, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.